Introducing Lauren Kelly: Director of the Biomedical Translation Bridge Program

16 September 2019

MTPConnect is excited to welcome Lauren Kelly to the team. Lauren starts work today in the role of Director of the Biomedical Translation Bridge program, based at the MTPConnect Head Office in Melbourne.

Lauren will work with Danielle Shand, the BTB Operations and Events Manager, to run the program along with our partners, BioCurate, UniQuest, the Medical Device Partnering Program and the Bridge and BridgeTech programs.

BTB is a $22.3 million MRFF initiative providing up to $1 million in matching funding to nurture the translation of new therapies, technologies and medical devices through to the proof of concept stage. Round 1 of the program saw 156 expressions of interest submitted across both medical devices and pharma and covering a range of therapeutic areas. As we assess these applications, watch this space for future announcements of selected projects, and new funding rounds.

Lauren specialises in the translation of science and technology and has extensive experience in developing, leading, and managing new initiatives, multidisciplinary teams, biobanks, pre-clinical and clinical R&D projects. Before joining MTPConnect, Lauren’s roles involved coordinating multinational, industry and academic drug discovery and translational research programs centring around metabolism and cardiovascular disease at Monash University. In addition, she developed and directed industry engagement initiatives for the Monash Biomedicine Discovery Institute.

Prior to her time at Monash, Lauren managed the research portfolio of the Cooperative Research Centre for Mental Health, with work focussed on the discovery and validation of biomarkers for Alzheimer’s disease, Parkinson’s disease, schizophrenia and mood disorders. Lauren has a Bachelor of Science and Master of Business (Science and Technology) from Monash University.

Please join us in welcoming Lauren to the MTPConnect team and follow her @LaurenEveKelly_.